Emily joined NEA in 2020 as an Associate on the Med Team working across the healthcare services, biopharma and medical device sectors. Prior to joining NEA, Emily was a member of the healthcare investment banking team at Goldman Sachs in New York City, where she worked on M&A and equity and debt financing transactions. She has also worked at the U.S. Department of Treasury, PwC, and several digital health startups.
Emily graduated summa cum laude from the University of Pennsylvania’s Vagelos Program in Life Sciences & Management, where she earned a B.S. in Finance from Wharton, a B.A. in Biology, and a certificate in healthcare policy as a Public Policy Research Scholar. During her time at Penn, Emily engaged in research on Castleman Disease with Dr. David Fajgenbaum, served as a project leader for 180 Degrees Consulting, and conducted due diligence on healthcare startups as part of the Wharton Impact Investing Partners health & wellness team.